Table II.
Intensity | CK-1ε (%) | DEC1 (%) | PCNA (%) | CD44 (%) |
---|---|---|---|---|
ASE | ||||
1 | 90 | 0 | 25 | 75 |
2 | 10 | 30 | 60 | 15 |
3 | 0 | 70 | 15 | 10 |
CIS | ||||
1 | 0 | 75 | 0 | 16 |
2 | 42 | 8 | 50 | 42 |
3 | 58 | 17 | 50 | 42 |
CK-1ε, casein kinase 1ε; DEC1, differentiated embryonic chondrocyte gene 1; PCNA, proliferating cell nuclear antigen; ASE, atypical squamous epithelium; CIS, carcinoma in situ.